Good Life Advisors’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400,000
| Closed | -$436K | – | 498 |
|
|
2024
Q4 | $436K | Hold |
400,000
| – | – | 0.03% | 316 |
|
|
2024
Q3 | $303K | Buy |
400,000
+75,000
| +23% | +$56.8K | 0.02% | 465 |
|
|
2024
Q2 | $403K | Buy |
325,000
+225,000
| +225% | +$279K | 0.03% | 305 |
|
|
2024
Q1 | $189K | Hold |
100,000
| – | – | 0.02% | 435 |
|
|
2023
Q4 | $264K | Sell |
100,000
-12,000
| -11% | -$31.7K | 0.03% | 354 |
|
|
2023
Q3 | $258K | Buy |
112,000
+36,000
| +47% | +$82.8K | 0.03% | 343 |
|
|
2023
Q2 | $277K | Hold |
76,000
| – | – | 0.03% | 323 |
|
|
2023
Q1 | $271K | Buy |
76,000
+1,000
| +1% | +$3.57K | 0.03% | 314 |
|
|
2022
Q4 | $214K | Buy |
75,000
+18,000
| +32% | +$51.3K | 0.03% | 320 |
|
|
2022
Q3 | $127K | Hold |
57,000
| – | – | 0.02% | 329 |
|
|
2022
Q2 | $142K | Buy |
+57,000
| New | +$142K | 0.02% | 339 |
|